KYMR
Kymera Therapeutics, Inc.
Stock
$107.39−2.73 (−2.48%)Close Oct 2, 2026
- Free cash flow, 2025
- −$234M
Free cash flow
Free cash flow by fiscal year
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | −$234M | — |
| 2024 | −$207M | — |
| 2023 | −$137M | — |
| 2022 | −$156M | — |
| 2021 | −$131M | — |
| 2020 | $79M | +354.9% |
| 2019 | $17M | — |